Author

A.-M. Gelinas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

E. Haddad· 1 shared J.-S. Milanese· 1 shared K. Beland· 1 shared M. Sasseville· 1 shared M.-E. Lalonde· 1 shared R. Marcotte· 1 shared S. Drouin· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Haddad

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivFeb 1, 2022

Genome-wide CRISPR Screens Identify Ferroptosis as a Novel Therapeutic Vulnerability in Acute Lymphoblastic Leukemia

M.-E. Lalonde, M. Sasseville, A.-M. Gelinas…·R. Marcotte

This study identifies ferroptosis as a therapeutic vulnerability in B-ALL through genome-wide CRISPR screens and validates it in patient-derived samples.

DOI 10.3324/haematol.2022.280786

humanwhole-genome sequencing

𝕏 PostBluesky